drugset
drugset / Trial / NCT05970718

A Trial to Learn if Different Doses of REGN7544 Are Safe in Healthy Adult Participants

NCT05970718 ↗

Phase 1 Completed 80 enrolled Regeneron Pharmaceuticals
RandomizedSequentialQuadruple-blindTreatment

Summary

The study is researching an experimental drug called REGN7544.The study is focused on healthy adults. The aim of the study is to see how safe and tolerable the study drug is in healthy adults. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in your blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)

Timeline

Start
2023-08-07
Primary completion
2024-07-22
Completion
2024-07-22

Drugs

EvaluationDrugModalityDoseRoute
Subject REGN7544 Monoclonal antibody — Intravenous

Indications

No indication recorded.